Two ASX shares at opposite ends of the market are catching my attention as the year draws to a close. The post Looking for ...

The ASX has spent most of 2025 swinging between optimism and anxiety, with inflation scares, rate hike speculation, and an AI ...

Blood plasma is big business — especially along the U.S.–Mexico border. Every day, thousands of Mexican citizens cross ...

An announcement from CSL ( ($AU:CSL) ) is now available. CSL Limited has announced an update on its ongoing share buy-back program, revealing that ...

CSL Ltd (ASX: CSL) shares have gotten walloped since August. Is the ASX 200 biotech giant now a bargain buy or one to steer ...

Australia’s long-term competitiveness depends on fostering innovation, investing in skills and supporting advanced ...